These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 29158366)
1. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis. Lin RJ; Green DL; Shah GL Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors. Mantia C; Zwicker JI Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488 [TBL] [Abstract][Full Text] [Related]
3. Intracranial hemorrhage in cancer patients treated with anticoagulation. Weinstock MJ; Uhlmann EJ; Zwicker JI Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980 [TBL] [Abstract][Full Text] [Related]
4. Challenges in anticoagulation for patients with brain tumors. Iyengar V; Patell R; Zwicker J Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073 [TBL] [Abstract][Full Text] [Related]
5. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients. Diaz M; Jo J Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. Zwicker JI; Karp Leaf R; Carrier M J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689 [TBL] [Abstract][Full Text] [Related]
7. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis. Rojas-Hernandez CM; Oo TH; García-Perdomo HA J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine? Ihnat DM; Mills JL; Hughes JD; Gentile AT; Berman SS; Westerband A J Vasc Surg; 1998 Nov; 28(5):800-7. PubMed ID: 9808846 [TBL] [Abstract][Full Text] [Related]
9. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma. Mahmood SS; Abtahian F; Fogerty AE; Cefalo P; MacKay C; Jaff MR; Weinberg I Am J Med; 2017 Jan; 130(1):77-82.e1. PubMed ID: 27477669 [TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in cancer patients. Deng A; Galanis T; Graham MG Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915 [TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians. Mumoli N; Barco S; Cei M; Giorgi-Pierfranceschi M; Campanini M; Fontanella A; Ageno W; Dentali F Intern Emerg Med; 2017 Jun; 12(4):437-443. PubMed ID: 27878663 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours. Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351 [TBL] [Abstract][Full Text] [Related]
14. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review. Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage. de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398 [TBL] [Abstract][Full Text] [Related]
16. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies. Swartz AW; Drappatz J Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555 [TBL] [Abstract][Full Text] [Related]
17. Management of venous thromboembolism in patients with primary and metastatic brain tumors. Gerber DE; Grossman SA; Streiff MB J Clin Oncol; 2006 Mar; 24(8):1310-8. PubMed ID: 16525187 [TBL] [Abstract][Full Text] [Related]
18. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding. Becattini C; Cimini LA; Carrier M Thromb Res; 2021 Apr; 200():41-47. PubMed ID: 33529872 [TBL] [Abstract][Full Text] [Related]
19. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis. Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875 [TBL] [Abstract][Full Text] [Related]
20. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis. Yang J; He Z; Li M; Hong T; Ouyang T J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]